Dynavax Technologies reported positive results in 153 adults aged 18 years to 55 years for Part A of the Phase-1 clinical trial of …
Shares of Dynavax Technologies Corp. rose about 6% on Feb.
Medigen Vaccine Biologics (MVC) and Dynavax Technologies (DVAX) have announced that MVC has obtained a Taiwan government subsidy for successfully initiating a Phase 1 clinical trial …
Vaccine-focused biopharma Dynavax Technologies (DVAX) has announced a collaboration to develop a universal influenza (flu) vaccine with the Icahn School of Medicine at Mount Sinai. Mount …
Dynavax Technologies (DVAX) is surging 40% in Tuesday’s pre-market trading after revealing that it expects one or more of its collaboration partners will commence …
On your mark, get set, go! The race is on to find an effective vaccine against COVID-19, the novel coronavirus that has spread to 471,000 …
Dynavax Technologies (NASDAQ:DVAX) after five years of “torturous” waiting has at long last garnered FDA approval for Heplisav-B. Cowen analyst Phil Nadeau anticipates hundreds of …
Kamada: Jefferies Sees 60% Upside for the Stock Kamada Ltd (NASDAQ:KMDA) has an upcoming PDUFA date on August 29, 2017 for its anti-rabies IgG …
Merck & Co., Inc.
Dynavax Technologies Corporation (NASDAQ:DVAX) reported financial results for the first quarter ended March 31, 2015. The Company had $97.
